Loading...
Alan Nieder Application PackageNIEDER ALAN M Last Name First Name Middle Initial 6340 PINETREE DR MIAMI BEACH Home Address City FL 33141 State Zip Code 305-674-2499 HomeWork alannieder@yahoo.com Email Address 7865149457 Cellular MIAMI BEACH Business Address 4302 ALTON ROAD #540 City FL State 33140 Zip Code MSMC Urology Occupation:Business Name: PHYSICIAN Please list your preferences in order of ranking [1] first choice [2] second choice, and [3] third choice. Please note that only three (3) choices will be observed by the City Clerk’s Office. (Regular Boards of City) Choice 1: Choice 2: Choice 3: Disability Access Committee Committee on the Homeless Sustainability Committee BOARD AND COMMITTEE APPLICATION FORM Note:If applying for the At-Large position of the Historic Preservation Board, please answer the below questions: Have you ever resided in one of the City's Historic Districts for at least one year?Yes No Address in City Historic District submitted. Professional License License Number Issuance Date Expire Date Medicine ME 87085 Note:If you are seeking appointment to a professional seat (e.g. attorney, architect, etc.), you must attach a copy of your currently effective corresponding professional license. Pursuant to City Code section 2-22(4) a, b and c: Members of Agencies, Boards, and Committees shall be affiliated with the city. This requirement shall be fulfilled in the following ways: YesResident of the City for a minimum of six (6) months: Demonstrate an ownership interest in a business established in the City for a minimum of six (6) months:Yes AFFILIATION WITH THE CITY OF MIAMI BEACH a. ● I am resident of:Middle Beach Or b. "Ownership Interest" shall mean the ownership of ten percent (10%) or more (including the ownership of 10% or more of the outstanding capital stock) in a business. "Business" shall mean any sole proprietorship, sponsorship, corporation, limited liability company, or other entity or business association. c.Full-time employee of such a business (for a minimum of six months); and I am based in an office or other location of the business that is physically located in Miami Beach (for a minimum of six months):No Notwithstanding the requirements set forth herein, the qualified full-time employee of a business must be approved by a 4/7th vote of the Mayor and City Commission. NOTE: Members of Agencies, Boards, and Committees shall be required to demonstrate compliance with the City affiliation requirements of section 2-22 (4) a and b of the Miami Beach City Code by executing an affidavit, stipulating that they have met either (or both) of said affiliation requirements. The original affidavit shall be filled with the Office of the City Clerk prior to being sworn in as a member. Or No● Have you ever been convicted of a felony:If yes, please explain in detail: ● Do you currently have a violation(s) of City of Miami Beach codes:No If yes, please explain in detail: ● Do you currently owe the City of Miami Beach any money:No If yes, please explain in detail: ● Are you currently serving on any City Boards or Committees:Yes If yes, which board? HEALTH ADVISORY COMMITTEE ● Are you presently a registered lobbyist with the City of Miami Beach?No ● I am applying for an appointment because I have special abilities, knowledge and experience. Please list below: HEALTH CARE AND MEDICINE NOTE: IF APPOINTED, YOU WILL BE REQUIRED TO FOLLOW CERTAIN LAWS THAT APPLY TO CITY BOARD/COMMITTEE MEMBERS. THESE LAWS INCLUDE, BUT ARE NOT LIMITED TO: o Prohibition from directly or indirectly lobbying city personnel (Miami Beach City Code section 2-459). o Prohibition from contracting with the city (Miami-Dade County Code section 2-11.1). o Prohibition from lobbying before board/committee you have served on for period of one year after leaving office (Miami Beach Code section 2-26) o Requirement to disclose certain financial interests and gifts (Miami-Dade County Code section 2-11.1). o Sunshine Law - Florida's Government-in-the-Sunshine Law was enacted in 1967. Today, the Sunshine Law regarding open government can be found in Chapter 286 of the Florida Statutes. These statutes establish a basic right of access to most meetings of Boards, Commissions, and other governing bodies of state and local governmental agencies or authorities. o Voting conflict - Form 8B is for use by any person serving at the county, city, or other local level of government on an appointed or elected Board, Council, Commission, Authority, or Committee. It applies equality to members of advisory and non-advisory bodies who are presented with a voting conflict of interest under Section 112.3143. Florida Statutes. ● In what organization(s) in the City of Miami Beach do you currently hold membership in? No Organization Information Submitted. ● List the address of all properties owned or in which you have an interest within the City of Miami Beach: Property 6340 PINETREE DR If so, which department and title?No● Are you now employed by the City of Miami Beach: ● Pursuant to City Code Section 2-25 (b): Do you have a parent, spouse, child, brother, or sister who is employed by the City of Miami Beach?No If "Yes", identify person(s) and department(s): No relative's information submitted. BOARD & COMMITTEE FINANCIAL ACKNOWLEDGEMENT STATEMENT Acknowledgement of fines/suspension for Board/Committee Members for failure to comply with Miami-Dade County Financial Disclosure Code Section 2-11.1(i)(2) I understand that no later than July 1, of each year all members of Boards and Committees of the City of Miami Beach, including those of a purely advisory nature, are required to comply with Miami-Dade County Financial Disclosure Requirements. One of the following forms must be filled with the City Clerk of Miami Beach, 1700 Convention Center Drive, Miami Beach, Florida, no later than 12:00 noon of July 1, of each year: 1. A "Source of Income Statement;" or 2. A "Statement of Financial Interests (Form 1)¹ ;" or 3. A Copy of your latest Federal Income Tax Return. Failure to file one of these forms, pursuant to the Miami-Dade County Code, may subject the person to a fine of no more than $500, 60 days in jail, or both. _____________________________ ¹ Members of the Planning Board and Board of Adjustment will be notified directly by the State of Florida, pursuant to F.S. §112.3145(1)(a), to file a Statement of Financial Interests (Form 1) with the Miami-Dade County Supervisor of Elections by 12:00 noon, July 1. Planning Board and Board of Adjustment members who file their Form 1 with the County Supervisor of Elections automatically satisfy the County’s financial disclosure requirement as a Miami Beach City Board/Committee member and need not file an additional form with the Office of the City Clerk. However, compliance with the County disclosure requirement does not satisfy the State requirement. DIVERSITY STATISTICS REPORT The following information is voluntary and has no bearing on your consideration for appointment. It is being asked to comply with City diversity reporting requirements. WhiteRace/Ethnic Categories What is your race? No details providedOther Description: Gender:Male Are you Spanish/Hispanic/ Latino? Mark the "No" box if not Spanish / Hispanic / Latino.No Physically Challenged:No I HEREBY ATTEST TO THE ACCURACY AND TRUTHFULNESS OF THE APPLICATION; AND I HAVE RECEIVED, READ AND WILL ABIDE BY CHAPTER 2, ARTICLE VII, OF THE MIAMI BEACH CITY CODE, ENTITLED “STANDARDS OF CONDUCT FOR CITY OFFICERS, EMPLOYEES AND AGENCY MEMBERS AND ALL OTHER APPLICABLE COUNTY AND/OR STATE LAWS AND STATUTES ACCORDINGLY.” I ALAN NIEDER agreed to the following terms on 2/23/2022 6:31:55 PM Received in the City Clerk's Office by: Name of Deputy Clerk Control No. Date Board and Committee Application Checklist: Please ensure you have provided all information before applying or reapplying to any Board and Committee. YES YES YES YES I have answered all questions fully. I have uploaded a current resume, photograph, and a copy of any applicable professional license. I have completed and attached the Board & Committee Financial Acknowledgment Statement. I have completed and attached the Diversity Statistics Report. If you have any questions, please contact the Office of the City Clerk via email: BC@miamibeachfl.gov or telephone: 305.673.7411 Note: Florida Statutes 119.071: The role of the Office of the City Clerk is to receive and maintain forms filed as public records. If your home address, telephone numbers, and/or photograph are exempt from disclosure and you do not wish your home address, telephone numbers, and/or photograph to be made public, please: 1) Use your office or other address for your mailing address; 2) Use your office or other telephone number for your contact number; and 3) Do not attach a photograph. Columbia University Curriculum Vitae 1. Date of preparation of C.V. January 7, 2022 2. Personal Data: Name: Alan M. Nieder, M.D. Citizenship: U.S.A. 3. Education: B.A. University of Michigan Ann Arbor, MI 1993 M.D. New York University School of Medicine New York, NY 1997 Alan M. Nieder, M.D. 2 4. Post-Doctoral Training (Residency & Fellowships): Resident, General Surgery New York University Medical Center New York, NY July 1997 – June 1999 Resident, Urology New York University Medical Center New York, NY July 1999 – June 2002 Chief Resident, Urology New York University Medical Center New York, NY July 2002 – June 2003 Fellow, Urologic Oncology University of Miami Medical Center Miami, FL Sept 2003 – Aug 2004 5. M.D. Licensure: Medical Licensure: New York State Medical License #211423 (1998) Florida State Medical License #ME87085 (2003) Drug Enforcement Agency License #BN8655891 (2004) Board Certification: Diplomat, American Board of Urology (2007, 2016) 6. Military Experience: N.A. Alan M. Nieder, M.D. 3 7. Professional Organizations and Societies American Urologic Association, 1998-date American Urologic Association, New York Section, 2004-2005 American Urologic Association, Southeast Section, 2005-date Florida Urological Society, 2006-date • Alternative Representative to the SESAUA Board of Directors, 2011- 2012 • Representative to the SESAUA Board of Directors, 2012-2015 • Nominating Committee, 2015-2017 • Executive Board Member, 2017-2019 Society of Urologic Oncology, 2010-date Society of University Urologists, 2012-2016 Society of Academic Urologists, 2016-date Alan M. Nieder, M.D. 4 8. Academic Appointments: Assistant Professor of Clinical Urology State University of New York (SUNY), at Stony Brook Department of Urology Stony Brook, NY September 2004 – May 2005 Assistant Professor of Clinical Urology University of Miami Miller School of Medicine Department of Urology Miami, FL June 2005 – June 2008 Assistant Professor of Clinical Urology Columbia University Department of Urology New York, NY July 2008 – November 2013 Associate Professor of Urology Columbia University Department of Urology New York, NY November 2013 - date Alan M. Nieder, M.D. 5 9. Hospital Appointments: Stony Brook University Hospital Stony Brook, NY September 2004 – May 2005 Jackson Memorial Hospital Miami, FL June 2005 – June 2008 Department of Veterans Affairs Medical Center Miami, FL 2005 – June 2008 Mount Sinai Medical Center Miami Beach, FL 2005 – date Co-Chief, Division of Urology Mount Sinai Medical Center Miami Beach, FL 2013 – date Alan M. Nieder, M.D. 6 10. Honors: 1993: B.A. with Honors, University of Michigan 1997: Fred S. Mandelbaum Award, for excellence in Pathology and Allied Sciences, New York University School of Medicine 1997: Samuel Soifer Memorial Award, for excellence in Urology, New York University School of Medicine 2000: Honorable Mention, 50th Ferdinand C. Valentine Resident Essay Contest, New York Academy of Medicine, Section of Urology 2000: Resident Traveling Scholar, International Volunteers in Urology, Bhopal, India 2003: 2nd Place, 53rd Ferdinand C. Valentine Resident Essay Contest, New York Academy of Medicine, Section of Urology 2006: Travel Award, American Urologic Association, Society of Basic Urologic Research, Madison, WI 2007: Honorable Mention, Journal of Urology, bladder cancer manuscript reviews 2008: American Urologic Association/Astellas Best Abstract, Bladder cancer: “Prostate Radiotherapy: what is the contemporary risk of bladder and rectal carcinoma?” Orlando, FL 2008: American Urologic Association Annual Meeting: Best poster during moderated poster session “Bladder cancer: detection and screening,” Orlando, FL 2009: Best Reviewer, Journal of Urology, prostate cancer manuscript reviews 2014: Best Reviewer, Journal of Urology, prostate cancer manuscript reviews 2015: Southeast Section of AUA, Visiting Professor, Florida Urologic Society Annual Meeting 2016: Top Reviewer, Urology, 2015-2016 Alan M. Nieder, M.D. 7 11. Fellowship & grant support: N.A. Alan M. Nieder, M.D. 8 12. Departmental & University Committees: University Committees: Member, Graduate Medical Education Committee Stony Brook Medical Center 2004 – 2005 Member, Graduate Medical Education Committee University of Miami/Jackson Memorial Hospital 2005 – June 2008 Member, Cancer Committee University of Miami/Jackson Memorial Hospital 2005 – June 2008 Member, Protocol Review Committee University of Miami/Jackson Memorial Hospital 2005 – 2007 Member, Admissions Committee University of Miami Miller School of Medicine 2006 – June 2008 Non-University Committees: Member, Bellevue House Staff Affairs Committee 2001 – 2003 Member, NYU Medical Center House Staff Council, 2001 – 2003 Co-Chairman, NYU Medical Center House Staff Council 2002 – 2003 Member, Graduate Medical Education Committee Mount Sinai Medical Center 2005 – date Member, Perioperative Resource Committee Mount Sinai Medical Center 2006 – date Alan M. Nieder, M.D. 9 Member, Credentialing Committee Mount Sinai Medical Center 2008 – 2013 Member, Surgical Review Committee Mount Sinai Medical Center 2009 – date Medical Executive Committee Mount Sinai Medical Center 2015 – 2017 Alan M. Nieder, M.D. 10 13. Teaching experience and responsibilities: Urologic Oncology Fellowship Director Mount Sinai Medical Center Department of Urology 2005 – date Residency Program Site Director Mount Sinai Medical Center Department of Urology University of Miami Miller School of Medicine 2005 – June 2008 Co-Assistant Residency Program Director Department of Urology University of Miami Miller School of Medicine 2007 – June 2008 Program Director, Urology Residency Mount Sinai Medical Center 2011 – date Alan M. Nieder, M.D. 11 14. Other professional activities: Editorial Responsibilities: Editorial Board: International Brazilian Journal of Urology, 2006-date Advances in Urology, 2013-2015 Reviewer: Journal of Urology, 2005-date International Brazilian Journal of Urology, 2005-date Cancer Letters, 2005-date Expert Review of Anticancer Therapy, 2006-date Hospital Physician, 2006-date Asian Journal of Andrology, 2006-date International Urogynecology Journal, 2006-date Urologic Oncology: Seminars and Original Investigations, 2006-date Urology, 2007-date European Urology, 2007-date BMC Cancer, 2009-date UroToday International Journal, 2009-date Radiation Oncology, 2011-date World Journal of Urology, 2011-date Clinical Epidemiology, 2012-date International Journal of Urology, 2012-date Urology Practice, 2014-date Alan M. Nieder, M.D. 12 Other Professional Activities: Panelist: Bladder Cancer Guidelines Society of International Urology/World Health Organization 2004 Invited Lecturer 2nd Annual Maurice Gonder Urology Symposium. SUNY Stony Brook 2005 Panelist: Prostate Cancer Symposium 16th Annual Challenging Cases in Urology Miami, FL February 2006 Invited Lecturer Jamaican Urologic Association Annual Meeting Kingston, Jamaica February 2009 Invited Lecturer The Grand Bahamas Medical and Dental Association 9th Annual Scientific Medical Conference Freeport, Bahamas 2009 Panelist: Management of Non-Invasive Bladder Cancer Florida Urological Society, Annual Meeting Naples, FL September 2009 Moderator: Advanced Prostate Cancer American Urologic Association Annual Meeting San Francisco, CA May 2010 Invited Lecturer Jamaican Urologic Association Annual Meeting Kingston, Jamaica February 2011 Abstract Reviewer: Advanced Prostate Cancer American Urologic Association Annual Meeting Atlanta, GA May 2012 Alan M. Nieder, M.D. 13 Invited Lecturer Jamaican Urologic Association Annual Meeting Kingston, Jamaica February 2013 Abstract Reviewer: Advanced Prostate Cancer American Urologic Association Annual Meeting San Diego, CA May 2013 Invited Lecturer Florida Urologic Society Annual Meeting Tampa, FL August 2013 Moderator: Prostate Cancer North Central Section American Urologic Association Annual Meeting Naples, FL October 2013 External Examiner Urology Final Oral Exam University of the West Indies Kingston, Jamaica December 2013 Invited Lecturer Jamaican Urologic Association Annual Meeting Kingston, Jamaica February 2014 Abstract Reviewer: Advanced Prostate Cancer American Urologic Association Annual Meeting Orlando, FL May 2014 Moderator: Prostate Cancer, Detection & Screening American Urologic Association Annual Meeting Orlando, FL May 2014 Invited Lecturer Florida Urologic Society Annual Meeting Miami Beach, FL August 2014 Alan M. Nieder, M.D. 14 Abstract Reviewer: Invasive Bladder Cancer American Urologic Association Annual Meeting New Orleans, LA May 2015 Moderator: Prostate Cancer, Detection & Screening American Urologic Association Annual Meeting New Orleans, LA May 2015 Invited Lecturer Florida International University HWCOM Medical Congress Miami Beach, FL July 2015 Southeast Section of AUA, Visiting Professor Florida Urologic Society Annual Meeting Orlando, FL August 2015 Invited Lecturer Moffitt Cancer Center: New Frontiers in Urologic Oncology Tampa, FL September 2015 Panelist: Prostate and Bladder Cancer Case Studies Winter Urologic Forum Vail, CO January 2016 Abstract Reviewer: Invasive Bladder Cancer American Urologic Association Annual Meeting San Diego, CA May 2016 Invited Lecturer Moffitt Cancer Center: Florida Bladder Cancer Symposium Ft Myers, FL November 2016 Panelist: Prostate and Bladder Cancer Case Studies Winter Urologic Forum Snowmass, CO January 2017 Alan M. Nieder, M.D. 15 Abstract Reviewer: Invasive Bladder Cancer American Urologic Association Annual Meeting Boston, MA May 2017 Moderator: Advanced Bladder Cancer American Urologic Association Annual Meeting Boston, MA May 2017 Abstract Reviewer: Invasive Bladder Cancer American Urologic Association Annual Meeting San Francisco, CA May 2018 Moderator: Bladder Cancer Southeast Section, American Urologic Association Annual Meeting Phoenix, AZ March 2019 Abstract Reviewer (Team leader): Invasive Bladder Cancer American Urologic Association Annual Meeting Chicago, IL May 2019 Moderator: Advanced Bladder Cancer American Urologic Association Annual Meeting Chicago, IL May 2019 Abstract Reviewer (Team leader): Invasive Bladder Cancer American Urologic Association Annual Meeting Washington, D.C. May 2020 Abstract Reviewer (Team leader): Invasive Bladder Cancer American Urologic Association Annual Meeting Las Vegas, NV September 2021 Moderator: Advanced Bladder Cancer American Urologic Association Annual Meeting Las Vegas, NV September 2021 Alan M. Nieder, M.D. 16 Moderator: Marketing, Technology & Liability Florida Urologic Society Annual Meeting Orlando, FL December 2021 Abstract Reviewer (Team leader): Invasive Bladder Cancer American Urologic Association Annual Meeting Washington, D.C. May 2022 Alan M. Nieder, M.D. 17 15. Publications: Original, Peer Reviewed Articles: 1. Lepor H, Nieder AM, Feser J, O’Connell C, Dixon C. Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates. Urology 49(3): 476-480, 1997. 2. Lepor H, Nieder AM, Feser J, O’Connell C, Dixon C. Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia. Journal of Urology, 158(1): 85-88, 1997. 3. Nieder AM, Chun T, Nitti V. Total vaginal prolapse with multiple vesical calculi after hysterectomy. Journal of Urology, 159(3): 983, 1998. 4. Lepor H, Nieder AM, Ferrandino M. Intraoperative and postoperative complications following radical retropubic prostatectomy in a consecutive series of 1,000 cases. Journal of Urology, 166(5): 1729-1733, 2001. 5. Nieder AM, Rosenblum N, Lepor H. Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy. Urology, 57(4): 737-741, 2001. 6. Lepor H, Nieder AM, Fraiman M. Early removal of the urinary catheter following radical retropubic prostatectomy is both feasible and desirable. Urology, 58(3): 425-429, 2001. 7. Stifelman M, Nieder AM. Prospective comparison of hand-assisted laparoscopic devices. Urology, 59(5): 668-672, 2002. 8. Stifelman MD, Handler T, Nieder AM, DelPizzo J, Taneja S, Sosa RE, Shichman SJ. Hand-assisted laparoscopy for large renal specimens: a multi-institutional study. Urology, 61(1): 78-82, 2003. 9. Nieder AM, Taneja SS, Zeegers M, Ostrer H. Genetic counseling for prostate cancer risk. Clinical Genetics, 63(3): 169-176, 2003. 10. Nieder AM & Taneja SS. The role of partial nephrectomy for renal cell carcinoma in contemporary practice. Urologic Clinics of North America, 30(3): 529-542, 2003. Alan M. Nieder, M.D. 18 11. Sved PD, Gomez P, Nieder, AM, Manoharan M, Kim S, Soloway MS. Upper tract tumor following radical cystectomy for transitional cell carcinoma of the bladder. British Journal of Urology International, 94(6): 785-789, 2004. 12. Walden PD, Globina Y, Nieder AM. Induction of anoikis by doxazosin in prostate cancer cells is associated with activation of caspase-3 and a reduction of focal adhesion kinase. Urology Research, 32(4): 261-265, 2004. 13. Nieder AM, Simon MA, Manoharan M, Kim SS, Soloway MS. Intraoperative cell salvage during radical prostatectomy: a safe technique for Jehovah’s Witnesses. International Brazilian Journal of Urology, 30(5): 377-379, 2004. 14. Zeegers MP, Kiemeny L, Nieder AM, Ostrer H. How strong is the association between CAG and GGM repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiology, Biomarkers & Prevention, 13(11): 1765-1711, 2004. 15. Nieder AM, Sved PD, Manoharan M, Gomez P, Kim S, Soloway MS. Urethral recurrence following cystoprostatectomy: Implications for urinary diversion and monitoring. Urology, 64(5): 950-954, 2004. 16. Nieder AM, Brausi M, Lamm D, O’Donnell M, Tomita K, Woo H, Jewett MAS. SIU/ICUD 2004 International Consensus Conference on Bladder Cancer: T1 Report. Urology, 66(Supp 6A): 108-125, 2005. 17. Nieder AM, Sved PD, Stein JP, Skinner DG, Soloway MS. Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette Guerin-induced bladder contractures. Urology, 65(5): 909-912, 2005. 18. Stifelman MD, Caruso RP, Nieder AM, Taneja SS. Robot-assisted laparoscopic partial nephrectomy. Journal of the Society of Laparoendoscopic Surgeons. 9(1): 83-86, 2005. 19. Sved PD, Nieder AM, Manoharan M, Gomez P, Meinbach DS, Kim SS, Soloway MS. Evaluation of analgesic requirements and postoperative recovery after radical retropubic prostatectomy utilizing long-acting spinal anesthesia. Urology, 65(3): 509-512, 2005. 20. Nieder AM, Manoharan M, Kim SS, Soloway MS. Neither alpha- blocker therapy nor cystography is required prior to early catheter removal after radical prostatectomy. British Journal of Urology International, 95(3): 323-325, 2005. Alan M. Nieder, M.D. 19 21. Nieder AM, Meinbach D, Manoharan M, Soloway MS. Transurethral bladder tumor resection: Intraoperative and postoperative complications in a residency setting. Journal of Urology, 174(6): 2307-2309, 2005. 22. Nieder AM, Carmack AJK, Sved PD, Kim SS, Manoharan M, Soloway MS. Intraoperative cell savage during radical prostatectomy is not associated with a higher rate of biochemical recurrence. Urology, 65(4): 730-734, 2005. 23. Madjar S, Frisher Z, Nieder AM, Waltzer W. Bladder wall abscess following midurethral sling procedure. International Urogynecology Journal, 17(2): 180-181, 2006. 24. Nieder AM, Lipke M, Madjar S. Transitional cell carcinoma associated with marijuana: case report and review of the literature. Urology, 67(1): 200.e5-200.e6, 2006. 25. Nieder AM, Simon MA, Kim SS, Manoharan M and Soloway MS. Radical cystectomy after BCG for high risk Ta, T1 and CIS: defining the risk of initial bladder preservation. Urology, 67(4): 737-741, 2006. 26. Nieder AM & Soloway MS. Eliminate the term “superficial” bladder cancer. Journal of Urology, 175(2): 417-418, 2006. 27. Nieder AM, John S, Messina CR, Granek IA, Adler HL. Are patients aware of the association between smoking and bladder cancer? Journal of Urology, 176(6): 2405-2408, 2006. 28. Araki M, Manoharan M, Vyas, S, Nieder AM, Soloway MS. A pelvic drain can often be avoided after radical retropubic prostatectomy: An update in 552 cases. European Urology, 50(6): 1241-1247, 2006. 29. Manoharan M, Reyes, M, Vyas, S, Nieder AM, Soloway MS. Concurrent radical retropubic prostatectomy and Lichtenstein inguinal hernia repair through a single modified Pfannenstiel incision: a 3-year experience. British Journal of Urology International, 98(2): 341-344, 2006. 30. Nieder AM & Manoharan M. The role of the surgeon & transurethral resection in the treatment of superficial bladder cancer. The Scientific World Journal Urology, 6: 2626-31, 2006. Alan M. Nieder, M.D. 20 31. Manoharan M, Reyes MA, Singal R, Kava BR, Nieder AM, Soloway MS. Orthotopic ileal neobladder reconstruction for bladder cancer: is adjuvant chemotherapy safe? International Brazilian Journal of Urology, 32(5): 529-535, 2006. 32. Reyes MA, Nieder AM, Kava BR, Soloway MS, Manoharan M. Does body mass index affect outcome after reconstruction of orthotopic neobladder? Urology, 69(3): 475-478, 2007. 33. Manoharan M, Ayyathurai R, Nieder AM, Soloway MS. Hemospermia following transrectal ultrasound-guided prostate biopsy: a prospective study. Prostate Cancer Prostatic Diseases, 10(3): 283-287, 2007. 34. Araki M, Nieder AM, Manoharan M, Yang Y, Soloway MS. Lack of progress in the early diagnosis of bladder cancer. Urology, 69(2): 270-274, 2007. 35. Nieder AM, Soloway MS, Herr H. Should we abandon the FISH Test? European Urology, 51(6): 1469-1471, 2007. 36. Nieder AM, Manoharan M, Yang Y, Soloway MS. Intraoperative cell savage during radical cystectomy does not affect long-term survival. Urology, 69(5): 881-884, 2007. 37. Nieder AM, MacKinnon JA, Lee DJ, Huang Y, Fleming LE, Koniaris LG. Florida bladder cancer trends 1981-2004: Minimal progress in the reduction of advanced disease. Journal of Urology, 179(2): 491-495, 2008. 38. Manoharan M, Ayyathurai R, Nieder AM, Soloway MS. Modified pfannenstiel approach for radical retropubic prostatectomy: a 3-year experience. Prostate Cancer Prostatic Diseases, 11(1): 74-78, 2008. 39. Nieder AM and Soloway MS. It’s not a radical prostatectomy, it’s a total prostatectomy. European Urology, 54(4): 715-716, 2008. 40. Sunkara R, Ayyathurai R, Nieder AM, Manoharan M. Delayed local recurrence following radiation therapy for muscle-invasive bladder cancer emphasizing the need for lifelong surveillance: a case report. The Scientific World Journal Urology, 19(8): 166-8, 2008. 41. Ayyathurai R, Manoharan M, Nieder AM, Kava B, Soloway MS. Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients. British Journal of Urology International, 101(7): 833-6, 2008. Alan M. Nieder, M.D. 21 42. Manoharan M. Ayyathurai R, de Los Santos R, Nieder AM, Soloway MS. Presentation and outcome in Hispanic following radical cystectomy. International Brazilian Journal of Urology, 34(6): 691- 698, 2008. 43. Nieder AM, Porter MP, Soloway MS. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population-based cohort study. Journal of Urology, 180(5): 2005- 2010, 2008. 44. Tunuguntala HS, Nieder AM, Manoharan M. Neobladder reconstruction following radical cystoprostatectomy for invasive bladder cancer. Minerva Urology Nephrology, 61(1); 41-54, 2009. 45. Nieder AM, MacKinnon JM, Fleming L, Kearney G, Sherman R, Huang Y, Lee DJ. Bladder cancer clusters in Florida: identifying populations at risk. Journal of Urology, 182(1): 46-51. 2009. 46. Brookfield KF, Cheung MC, Gomez C, Yang R, Nieder AM, Lee DJ, Koniaris LG. Survival disparities among African American women with invasive bladder cancer in Florida. Cancer, 115(18): 4196-4029, 2009. 47. Nieder AM, Lotan Y, Nuss GR, Langston JP, Vyas S, Manoharan M, Soloway MS. Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey. Urologic Oncology, 28(5): 500-503, 2010. 48. Nieder AM, Nebhnani J, Bianco F. The optimal diagnosis of urothelial carcinioma of the bladder. Current Cancer Therapy Reviews, 7(4): 267-271, 2011. 49. Delto JC, Wayne GF, Garces S, Medina AM, Nieder AM. An adult case of paratesticular spindle cell rhabdomyosarcoma. Urology Case Reports, 2: 126-128, 2014. 50. Badani KK, Rothberg MB, Bergman A, Silva MA, Shapiro EY, Nieder AM, Patel T, Bhandari A. Robotic-assisted nephroureterectomy and bladder cuff excision without patient or robot repositioning: description of modified port placement and technique. J Laparoendoscopic Adv Surg Tech, 24(9): 647-650, 2014. 51. Delto JC, Wayne G, Yanes R, Nieder AM, Bhandari A. Reducing robotic prostatectomy costs by minimizing instrumentation. Journal of Endourology, 29(5): 556-560, 2015. Alan M. Nieder, M.D. 22 52. Whalen MJ, RiChard JL, Ghandour R, Lipsky M, Piecuch M, Benson MC, Nieder AM, DeCastro GJ, McKiernan JM. Lessons learned from routine intraoperative ureteral margin frozen sections during radical cystectomy. Urology Practice, 2:2, 190-195, 2015. 53. Yanes R, Glamore M, Delto JC, Bhandari A, Nieder AM. Urology patients and the internet: socioeconomic status and language skills significantly impact usage. Urology Practice, 2(5): 317-320, 2015. 54. Delto JC, Garces S, Gaffaripour T, Omarzia Y, Nieder AM. Giant fungating basal cell carcinoma of the scrotum. Urology, 91(5):e1-2, 2016. 55. Delto JC, Wayne G, Sidhu AS, Yanes R, Bhandari A, Nieder AM. The Single wire ureteral access sheath: both safe & economical. Advances In Urology, 2016; 2016:6267953. Epub 2016 Nov 15. PMID: 27974887 56. Sidhu AS, Marten E, Bodoukhin N, Wayne G, Nagoda E, Bhandari A, Nieder AM. Alexis wound retractor for radical cystectomy: a safe and effective method for retraction. Advances in Urology, 2018; 2018:8727301. PMID: 30627153 57. Marten E, Garcia-Gil M, Bhandari A, McKiernan JM, Nieder AM. Barriers to neaoadjuvant chemotherapy prior to radical cystectomy in a single referral center in South Florida. Urology Practice, in press. 58. Ramirez E, Morano J, Beguiristain T, Castro G, Rodriguez de la Vega P, Nieder AM, Barengo N. Insurance status as a modifier of the association between race and stage of prostate cancer diagnosis in Florida during 1995 and 2013. Cancer Epidemiology, 59 (2019): 104- 108. PMID: 30731402 59. Morales J, Malles A, Kimble M, Rodriguez de la Vaga P, Castro G, Nieder AM, Barengo N. Does health insurance modify the association between race and cancer-specific survival in patients with Urinary Bladder Malignancy in the U.S.? International Journal of Environmental Research and Public Health, 2019 Sep 13; 16(18). PMID: 31540198 60. Etra A, Wong V, Barengo NC, Nieder AM, Polackwich S. A Comparison Between AMS 700 and Coloplast Titan: A Systematic Literature Review. Cureus 12(11): e11350. 2020. PMID: 33304685 Alan M. Nieder, M.D. 23 61. Jivanji D, Jamieson S, Mallory C, Wong V, Barrau S, Atri E, Castro G, Barengo NC, Nieder AM. The Association Between Race and 5-year Survival in Patients with Clear Cell Renal Cell Carcinoma: A Cohort Study. Urology, 148:185-191. 2021. PMID: 33285213 62. Wayne G, Wei J, Atri E, Wong V, Garcia-Gil M, Pereria J, Nieder AM, Bhandari A. Trends in positioning for robotic prostatectomy: results from a survey of the endourological society. Cureus 12(1): e12628, 2021. Doi:10.7759/cureus.12628. PMID: 33585117 63. Jamieson S, Mallory C, Jivanji D, Perez A, Castro G, Barengo NC, Pereira J, Nieder AM. The role of health literacy in prostate cancer screening. Urology, 2021. PMID: 34375651 Alan M. Nieder, M.D. 24 Chapters 1. Nieder AM & Lepor H. “Complications of Pharmacotherapy,” in Taneja S, Smith RB, Ehrlich RM (Eds.): Complications of Urologic Surgery, 3rd edition. W.B. Saunders, pp 69-79, 2001. 2. Nieder AM & Soloway MS. “Cystoscopy,” in Lerner SP, Schoenberg MP, Sternberg CN (Eds.): Textbook of Bladder Cancer. Taylor & Francis, pp 179-186, 2006. 3. Jewett MAS, Nieder AM, Brausi M, Lamm D, O’Donnell M, Tomita K, Woo H. “T1 urothelial carcinoma of the bladder,” in Soloway MS, Carmack A, Khoury S (Eds): Bladder Tumors. Health Publication LTD, pp 189-217, 2006. 4. Kava BR, Nieder AM, Soloway MS. “Treatment of low risk prostate cancer,” in Feneley M & Payne H (Eds): Therapeutic Strategies in Prostate Cancer. Oxford Press, pp 99-114, 2007. 5. Manoharan M & Nieder AM. “Cystectomy and urinary diversion,” in Nargund VH, Ragahavan D, Sandler HM (Eds): Handbook of Urologic Oncology. Springer, 2007. 6. Nieder AM, Manoharan M. “High-grade prostatic intraepithelial neoplasia,” in Silva O & Abdel-Wahab M (Eds): Prostate Cancer: A Practical Guide. Elsevier, pp 110-114, 2008. 7. Kava B, Manoharan M, Nieder AM, Soloway M. “Radical prostatectomy,” in Silva O & Abdel-Wahab M (Eds): Prostate Cancer: A Practical Guide. Elsevier, pp 153-178, 2008. 8. Nieder AM & Soloway MS. “Future directions in nephron sparing surgery,” in Soloway MS & Sasidarahan K (Eds): Nephron Sparing Surgery. Informa Healthcare LTD, pp 147-189, 2008. 9. Nieder AM & Soloway MS. “Preparation for prostate biopsy,” in Jones JS (Ed): Prostate Biopsy: Indications, Techniques and Complications. Humana Press, pp 97-104, 2008. 10. Cooke T & Nieder AM, “Complications of Pharmacotherapy,” in Taneja S (Ed.): Complications of Urologic Surgery, 4th edition. Saunders Elsevier, pp 85-94, 2010. Alan M. Nieder, M.D. 25 Letters to the Editor: 1. Nieder AM, Soloway MS, Jewett MAS. Re: Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? Journal of Urology, 178(1): 352, 2007. 2. Nieder AM, Soloway MS, Herr H. Reply to Tine Hajdinjak and Nadja Kokalj-Vokac's Letter to the Editor re: Mecedes Marin-Aguilera, Lourdes Mengual, Maria Jose Ribal et al. Utility of Fluorescence In Situ Hybridization as a Non-invasive Technique in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma. Eur Urol 2007; 51:409-15 and Alan M. Nieder, Mark S. Soloway and Harry W. Herr. Should We Abandon the FISH Test? European Urology, 52(1): 290, 2007. 3. Nieder AM and Lee DJ. Re: The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. Journal of Urology, 180(6): 2713, 2008. Alan M. Nieder, M.D. 26 Invited Commentary: 1. Nieder AM & Soloway MS. We are not yet ready to abandon cystoscopy. Nature Clinical Practice Urology, 4(3):130-1, 2007. 2. Nieder AM. Regarding: Herr HW & Donat SM. Management of low- grade papillary bladder tumors. Journal of Urology, 178(4): 1205, 2007. 3. Nieder AM. Regarding: Pantuck AJ, Baniel J, Kirkali Z, Klatte T, Zomorodian N, Yossepowitch O, Belldegrun AS. A novel resectoscope for transurethral resection of bladder tumors and the prostate. Journal of Urology, 178(6): 2336, 2007. 4. Nieder AM. Regarding: Dhar N, Klein EA, Reuther A, Thalmann GN, Madersbacher S and Studer UE. Outcome of radical cystectomy with limited or extended pelvic lymph node dissection. Journal of Urology, 179(3): 878, 2008. 5. Nieder AM. Regarding: Singh A, Kinoshita Y, Rovito PM, Landas S, Silberstein J, Nsouli I, Wang CY and Haas GP. Higher than expected association of clinical prostate and bladder cancers. Journal of Urology, 179(5 supplement): S6, 2008. 6. Nieder AM. Regarding: Lund L, Jacobsen J, Norgaard M, Sorensen HT, Borre M, Blot WJ, McLaughlin JK. Prognostic impact of comorbidities on renal cancer, 1995-2006: Danish population-based Study. Journal of Urology, 182(1): 40, 2009. 7. Nieder AM. Regarding: Verhoest G, Avakian R, Bensalah K, Thuret R, Ficcara V, Artibani W, et al. Urinary collecting system invasion is an independent prognostic factor in organ confined renal cell carcinomas. Journal of Urology, 182(3): 859, 2009. 8. Nieder AM. Regarding: Fisher MB, Svatek RS, Hegarty PK, McGinniss JE, Hightower C, Grossman HB, et al. Cardiac history and the risk of post-cystectomy cardiac complications. Urology, 74(5): 1089, 2009. 9. Nieder AM. Regarding: Wu WJ, Ke HL, Yang YH, Li CC, Chou YH, Huang CH. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? Journal of Urology, 183(1): 61, 2010. 10. Nieder AM. Regarding: Samplaski MK, Hernandez AV, Gill IS and Simmonds MN. C-Index associates with functional outcomes after laparoscopic partial nephrectomy. Journal of Urology, 184(6): 2263, 2010. Alan M. Nieder, M.D. 27 11. Nieder AM. Regarding: Yafi FA, Aprikian AG, Tanguay S, Kassouf W. Reluctance of general practioners to refer gross hematuria patients to urology. Canadian Urologic Association Journal, 5(2): 97-102, 2011. 12. Nieder AM. Regarding: Todenhöfer T, Hennenlotter J, Kühs U, Tews V, Gakis G, Aufderklamm S, Stenzl A, Schwentner C. Influence of urinary tract instrumentation and inflammation of the performance of urine markers for the detection of bladder cancer. Urology, 79(3): 625, 2012. 13. Nieder AM. Regarding: Herati AS, Montag S, Andonian S, Shapiro EY, Akerman M, Kavoussi LR, Richstone L. Audio and visual analysis of urologic laparoscopic and robotic skills: objective criteria for surgical skill evaluation. Urology, 80(6): 1282, 2012. 14. Nieder AM. Regarding: Trends in the Utilization of Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Results from the National Cancer Database. Urology, 83(1): 80, 2014. 15. Nieder AM. Regarding: Expert witness testimony in urology malpractice litigation. Urology, 83(4): 704-709, 2014. 16. Nieder AM. Regarding: Kim K, Jang E, Kim Y, Moon HL. Tamsulosin treatment affecting patient reported outcomes in BPH-associated depressive symptoms. Urology, 87: 172-177, 2016. 17. Nieder AM. Regarding: Krouwel E, Palacios L, Putter H, Pelger R, Kloens G, Elzevier H. Omissions in Urology Residency Training Regarding Sexual Dysfunction Subsequent to Prostate Cancer Treatment: Identifying a Need. Urology, 90(4): 19-26, 2016. 18. Nieder AM. Regarding: Cohen A, Lapin B, Wang C, Helfand B, Victorson D, Novakovic K. Variation in testosterone levels and HRQOL in men diagnosed with prostate cancer on active surveillance. Urology (94): 180-187, 2016. 19. Nieder AM. Regarding: Watts KL, Ghosh P, Stein S, Ghavamian R. Value of nephrometry score constituents on perioperative outcomes and split renal function in patients undergoing minimally invasive partial nephrectomy. Urology, 99: 112-117, 2017. 20. Nieder AM. Regarding: Leung A, Hugar L, Patil D, et al. The Clinical Course of Patients with PSA≥100 ng/mL: insight into a potential population for targeted PSA screening. Urology, 117: 101-107, 2018. Alan M. Nieder, M.D. 28 21. Nieder AM. Regarding: Smoking cessation after a urological cancer diagnosis. Journal of Urology, 205: 1284, 2021. Alan M. Nieder, M.D. 29 Invited Review Articles: 1. Nieder AM & Soloway MS. Diagnosing bladder cancer. US Genito- Urinary Disease, 32-33, 2006. 2. Nieder AM. Team approach to prostate cancer. Coping, 23(3): May/June 2009. 3. Nieder AM & Yanes R. Team approach to prostate cancer. Coping, May/June 2013. Alan M. Nieder, M.D. 30 Published Abstracts: 1. Nieder AM, Feser J, O’Connell C, Dixon C, Lepor H. Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates. Poster presentation at AUA Annual Meeting, New Orleans LA, April 1997. Abstract #745. 2. Nieder AM, Rosenblum N, Lepor H. Relative effectiveness of two different doses of recombinant erythropoietin (rEPO) in men undergoing radical retropubic prostatectomy. Poster presentation at AUA Annual Meeting, Atlanta GA, April 2000. Abstract #1295. 3. Lepor H, Nieder AM, Ferrandino M. The intraoperative and postoperative complications following radical retropubic prostatectomy in a consecutive series of 1,000 cases. Poster presentation at AUA Annual Meeting, Anaheim CA, June 2001. Abstract #1347. 4. Lepor H, Nieder AM, Fraiman M. Early removal of the urinary catheter following radical retropubic prostatectomy is both feasible and desirable. Podium presentation at AUA Annual Meeting, Anaheim CA, June 2001. Abstract #618. 5. Walden PD, Globina Y, Nieder AM. Investigation of the non- adrenergic, apoptotic mechanism of action of doxazosin in the prostate. Poster presentation at AUA Annual Meeting, Orlando FL, May 2002. Abstract #869. 6. Nieder AM, Carmack AJK, Sved PD, Kim SS, Manoharan M, Soloway MS. Intraoperative cell savage during radical prostatectomy is not associated with a higher rate of biochemical recurrence. Podium presentation at Society of International Urology World Congress, Honolulu HI, October 2004. Abstract #PD-4.11. British Journal of Urology International, 94 (Supp 2): 60, 2004. 7. Nieder AM, Sved PD, Manoharan M, Gomez P, Kim SS, Soloway MS. Urethral recurrence following cystoprostatectomy: Implications for urinary diversion and monitoring. Poster presentation at Society of International Urology World Congress, Honolulu HI, October 2004. Abstract #MP-3.12. British Journal of Urology International, 94 (Supp 2): 16, 2004. 8. Nieder AM, Sved PD, Manoharan M, Gomez P, Meinbach DS, Kim SS, Soloway MS. Revised radical retropubic prostatectomy: a challenge to laparoscopic radical prostatectomy? Poster presentation at Society of International Urology World Congress, Honolulu HI, Alan M. Nieder, M.D. 31 October 2004. Abstract #UP-9.33. British Journal of Urology International, 94 (Supp 2): 221, 2004. 9. Nieder AM, Sved PD, Manoharan M, Soloway MS. Modified pfannenstiel incision for radical prostatectomy: a challenge to laparoscopy. Video presentation at Society of International Urology World Congress, Honolulu HI, October 2004. Abstract #V-5.07. British Journal of Urology International, 94 (Supp 2): 161, 2004. 10. Simon M, Nieder AM, Manoharan M, Soloway MS. Radical cystectomy after BCG: are we waiting too long? Podium presentation at AUA Annual Meeting, San Antonio, TX, May 2005. Abstract #1120. 11. Manoharan M, Nieder AM, Vyas S, Soloway MS. Concurrent inguinal hernia repair and radical retropubic prostatectomy through a single modified Pfannenstiel incision: 3 year experience. Poster presentation at AUA Annual Meeting, Atlanta, GA, May 2006. Abstract #94662. Journal of Urology, 175 (Supp 4): 518, 2006. 12. Luongo T, Ayyathurai R, Nieder AM, Manoharan M, Soloway MS. Lymphovascular invasion in bladder cancer: is it an important prognostic indicator? Podium presentation at AUA Annual Meeting, Anaheim, CA, May 2007. Abstract #1665. Journal of Urology, 177 (Supp 4): 552, 2007. 13. Nieder AM, Manoharan M, Vyas S, Soloway MS. Evaluation and work-up of hematuria among primary care physicians in Miami-Dade County: an anonymous questionnaire-based survey. Poster presentation at AUA Annual Meeting, Anaheim, CA, May 2007. Abstract #1082. Journal of Urology, 177 (Supp 4): 357, 2007. 14. Manoharan M, Vyas S, Ayyathurai R, Nieder AM, Soloway MS. Radical cystectomy in octogenarians: is routine post-operative intensive care monitoring necessary? Podium presentation at AUA Annual Meeting, Anaheim, CA, May 2007. Abstract #572. Journal of Urology, 177 (Supp 4): 191, 2007. 15. Ayyathurai R, Manoharan M, Nieder AM, Soloway MS. Factors affecting potency following radical retropubic prostatectomy: results from 1620 consecutive patients. Poster presentation at AUA Annual Meeting, Anaheim, CA, May 2007. Abstract #558. Journal of Urology, 177 (Supp 4): 186, 2007. 16. Manoharan M, Reyes MA, Nieder AM, Kava BR, Soloway MS. Does body mass index affect outcome after reconstruction of orthotopic neobladder? Poster presentation at AUA Annual Meeting, Alan M. Nieder, M.D. 32 Anaheim, CA, May 2007. Abstract #191. Journal of Urology, 177 (Supp 4): 64, 2007. 17. Ayyathurai R, Luongo T, Nieder AM, Manoharan M, Soloway MS. Outcomes of pT0 at radical cystectomy without neoadjuvant therapy. Poster presentation at AUA Annual Meeting, Orlando, FL, May 2008. Abstract #1617, Journal of Urology, 179 (Supp 4): 552, 2008. 18. Nieder AM, Porter MP, Soloway MS. Prostate Radiotherapy: What is the contemporary risk of bladder and rectal carcinoma. Poster presentation at AUA Annual Meeting, Orlando, FL, May 2008. Abstract #935, Journal of Urology, 179 (Supp 4): 322, 2008. 19. Nieder AM, MacKinnon JA, Huang Y, Fleming LE, Koniaris LG, Lee DJ. Florida state bladder cancer clusters: Identifications of populations at risk. Poster presentation at AUA Annual Meeting, Orlando, FL, May 2008. Abstract #933, Journal of Urology, 179 (Supp 4): 322, 2008. 20. Nieder AM, Ruiz A. What do most patients with bladder cancer ultimately succumb to: A 25-year follow-up of a single institution’s bladder cancer registry (1980-2004). Podium presentation at AUA Annual Meeting, San Francisco, CA, May 2010. Abstract #1026. Journal of Urology, 183(supp 4): e399. 21. Neithlich T, Reddy N, Nieder AM, Neithlich J. Reducing radiation exposure with imaging patients with hematuria. Poster presentation at AUA Annual Meeting, Washington D.C., May 2011. Abstract #2217, Journal of Urology, 185 (supp 4), e890. 22. Bergman A, Patel T, Kanagarajah P, Nieder AM, Bhandari A, Badani K. Technique of robotic assisted nephroureterectomy with bladder cuff excision: no patient or robotic positioning necessary. Video presentation at AUA Annual Meeting, San Diego, CA, May 2013. Abstract v1271. 23. Hamada A, Santos J, Nieder AM, Bhandari A. Minimizing warm ischemia during robotic assisted partial nephrectomy. Video presentation at AUA Annual Meeting, Orlando, FL, May 2014. 24. Diaz GA, Yanes RE, Bhandari A, Nieder AM. High risk of priapism in recreational intracavernosal drug abusers. Podium presentation at AUA Annual Meeting, New Orleans, LA, May 2015. Abstract PD2- 08. Alan M. Nieder, M.D. 33 25. Sidhu AJ, Wayne GJ, Bhandari A, Nieder AM. Alexis wound protector reduces wound infection during radical cystectomy and urinary diversion. Poster presentation at AUA Annual Meeting, San Diego, CA, May 2016. Abstract MP23-15. Journal of Urology, 195:4S, e267. 26. Delto JC, Nieder AM, Bhandari A. Salvage robotic partial nephrectomy after cryoablation. Video presentation at AUA Annual Meeting, Boston, MA, May 2017. Abstract V3-07. Journal of Urology, 197(4), e290, 2017 27. Garcia-Gil M, Weinstein C, Martin E, Boudoukin N, Nieder AM. Neoadjuvant Chemotherapy Utilization in South Florida: A Single- Institution Report of Barriers to Receipt of Neoadjuvant Chemotherapy. Poster presentation at AUA Annual Meeting, San Francisco, CA, May 2018. Journal of Urology, 199(4), e947, 2018. 28. Nolte A, Wayne G, Nagoda E, Wong V, Cedeno J, Perez A, Nieder AM. Urinary Exosome Test and MP-MRI for prostate caner screening: balancing costs and benefits. Poster presentation at AUA Annual Meeting, May 2020. Abstract MP 27-08. Journal of Urology, 203(4S): e412-413, 2020 Alan M. Nieder, M.D. 34 Audio-Taped Discussions: 1. Nieder AM. “Conversations with Urologic Oncology Investigators”, in Love N (ed): Prostate Cancer Update, Vol 5, Issue 2, 2006. 2. Nieder AM. Meet the Professors: A case-based discussion on the management of prostate cancer in the localized and metastatic settings, in Love N (ed): Prostate Cancer Update, Vol 1, Issue 1, 2007. Alan M. Nieder, M.D. 35 Presented Abstracts: 1. Stifelman M, Nieder AM. A prospective comparison of hand-assisted laparoscopic devices. Poster presentation at World Congress of Endourology, Bangkok, Thailand, November 2001. 2. Simon M, Nieder AM, Manoharan M, Soloway MS. Radical cystectomy after BCG: are we waiting too long? Podium presentation at Southeast Section AUA, Charleston, SC, March 2005. 3. Araki, M, Manoharan M, Nieder AM, Soloway MS. Lack of progress: the early diagnosis of bladder cancer. Poster presentation at Society of Urologic Oncology Meeting, Bethesda, MD, December 2005. 4. Cohen B, Manoharan M, Reyes M, Nieder AM, Soloway MS. Orthotopic neobladder reconstruction following cystectomy for bladder cancer: is adjuvant chemotherapy safe? Poster presentation at Society of Urologic Oncology Meeting, Bethesda, MD, December 2005. 5. Nieder AM, Ayyathurai R, Manoharan M, Soloway MS. Can bladder wash cytology predict pathologic outcomes at TURBT? Poster presentation at Society of Urologic Oncology Meeting, Bethesda, MD, December 2006. 6. Nieder AM, Manoharan M, Vyas S, Soloway MS. Evaluation and work- up of hematuria among primary care physicians in Miami-Dade County: an anonymous questionnaire-based survey. Poster presentation at Southeastern Section AUA, Orlando, FL, March 2007. 7. Nieder AM, MacKinnon JA, Lee DJ, Huang Y, Fleming LE, Koniaris LG. Florida bladder cancer trends 1981-2004: a population still at risk. Poster presentation at American Society of Preventative Oncology, Houston, TX, March 2007. 8. Nieder AM, MacKinnon JA, Lee DJ, Huang Y, Fleming LE, Koniaris LG. Florida bladder cancer trends 1981-2004: Advanced cases continue to plaque a population at risk. Podium presentation at North Central Section AUA, Hollywood, FL, October 2007. 9. Nieder AM, MacKinnon JA, Lee DJ, Huang Y, Fleming LE, Koniaris LG. Florida bladder cancer trends 1981-2004: Advanced cases continue to plaque a population at risk. Poster presentation at American Association of Cancer Research: Frontiers in Cancer Prevention Research meeting, Philadelphia, PA, December 2007. 10. Nieder AM, Ruiz A. What do most patients with bladder cancer ultimately succumb to: A single institution bladder cancer registry with Alan M. Nieder, M.D. 36 25-year follow-up (1980-2004). Podium presentation at Southeastern Section AUA, Miami Beach, FL, March 2010. 11. Kanagarajah P, Reid G, Bhandari A, Nieder AM. Is routine follow-up ultrasound necessary after ureteroscopy and laser lithotripsy? Podium presentation at Southeastern Section AUA, Williamsburg, VA, March 2013. 12. Yanes R, Kanagarajah P, Bhandari A, Nieder AM. Can a negative CertNDx urine test obviate the need for further hematuria workup? Poster presentation at Southeastern Section AUA, Williamsburg, VA, March 2013. 13. Kanagarajah P, Nieder AM, Santos J, Bhandari A. Robotic nephroureterectomy without re-docking and re-positioning the robot. Poster presentation at Southeastern Section AUA, Williamsburg, VA, March 2013. 14. Hamada A, Santos-Cortes J, Bhandari A, Nieder AM. Short-term experience with a modified technique of uretero-ileal anastomosis during radical cystectomy and urinary diversion. Poster presentation at Southeastern Section AUA, Hollywood, FL, March 2014. 15. Garces S, Delto J, Nieder AM, Medina AM. An adult case of paratesticular spindle cell rhabdomyosarcoma. Poster presentation at College of American Pathologists, Chicago, IL, September 2014. 16. Delto J, Sidhu AJ, Wayne G, Yanes R, Bhandari A, Nieder AM. Careful selection of disposables can minimize the cost of ureteroscopy. Poster presentation at Southeastern Section AUA, Savannah, GA, March 2015. 17. Sidhu AJ, Wayne GJ, Bhandari A, Nieder AM. Alexis wound protector reduces wound infection during radical cystectomy and urinary diversion. Poster presentation at Southeastern Section AUA Nashville, TN, March 2016. 18. Sidhu AJ, Wayne GJ, Bhandari A, Nieder AM. Almivopan for reduced postoperative ileus and length of stay after cystectomy: The Mount Sinai experience. Poster presentation at Southeastern Section AUA, Nashville, TN, March 2016. 19. Garcia-Gil M, Sidhu AJ, Bhandari A, Nieder AM. Costs of training urology residents in robotic vs. open cystectomy: duplication of personnel in an academic setting. Poster presentation at Southeastern Section AUA, Nashville, TN, March 2016. 20. Yanes R, Delto J, Sidhu A, Caso J, Bhandari A, Nieder AM. A Novel Technique for “Contained” Aspiration and Irrigation of Priapism (CAIP). Alan M. Nieder, M.D. 37 Poster presentation at Annual Meeting of the Southeastern Section AUA, Nashville, Tennessee, March, 2016. 21. Delto JC, Lopez J, Yanes R, Sidhu AS, Garcia-Gil M, Nieder AM, Bhandari A. Single Digit Warm Ischemia Time – Is There a Benefit? Poster presentation at World Congress of Endourology. Capetown, South Africa. November 2016. 22. Delto JC, Lopez J, Yanes R, Sidhu AS, Garcia-Gil M, Nieder AM, Bhandari A. Warm Ischemia Time – Does Size Matter? Poster presentation at World Congress of Endourology. Capetown, South Africa. November 2016. 23. Delto JC, Lopez J, Yanes R, Sidhu AS, Garcia-Gil M, Nieder AM, Bhandari A. Modified Running V-loc Technique Minimizes Warm Ischemia Time. Poster presentation at World Congress of Endourology. Capetown, South Africa. November 2016. 24. Delto JC, Garcia-Gil , Bodoukhin N, Sidhu AS, Diaz G, Nieder AM. Molecular Grading with FGFR3 and Ki67: A Reliable Tool in Non- Muscle Invasive Bladder Cancer? Poster presentation at Florida Bladder Cancer Symposium. November 2016. 25. Garcia-Gil M, Wayne G, Castro E, Delto JC, Sidhu AS, Diaz G, Caso J, Bhandari A, Nieder AM. Benefits of Cutaneous Ureterostomy for Urinary Diversion in Elderly Cystectomy Patients: Improved Operative Time and Length of Stay. Poster presentation at Florida Bladder Cancer Symposium. November 2016. 26. Delto JC, Lopez J, Sidhu AS, Garcia-Gil M, Diaz G, Nieder AM, Bhandari A. Single Digit Warm Ischemia Time – Is There a Benefit? Poster presentation at Southeastern Section AUA. Austin, TX. March 2017. 27. Garcia-Gil M, Wayne G, Castro E, Delto JC, Sidhu AS, Diaz G, Caso J, Bhandari A, Nieder AM. Benefits of Cutaneous Ureterostomy for Urinary Diversion in Elderly Cystectomy Patients: Improved Operative Time and Length of Stay. Poster presentation at Southeastern Section AUA. Austin, TX. March 2017. 28. Delto JC, Garcia-Gil M, Bodoukhin N, Sidhu AS, Diaz G, Nieder AM. Molecular Grading with FGFR3 and Ki67: A Reliable Tool in Non- Muscle Invasive Bladder Cancer? Poster presentation at Southeastern Section AUA. Austin, TX. March 2017. 29. Garcia-Gil M, Dahan J, Nieder AM. Role of coffee after cystectomy with ileal conduit for promoting bowel function. Poster presentation at Southeastern Section AUA. Orlando, FL, March 2018. Alan M. Nieder, M.D. 38 30. Garcia-Gil M, Marten E, Weinstein CS, Bodoukhin N, Dahan J, Bhandari A, Nieder AM. Pelvic radiation as a risk factor for the development of ureteroanastomotic strictures in patients undergoing radical cystectomy. Poster presentation, Florida International University Research Symposium, April 2018. 31. Beguiristain T, Morano J, Ramirez E, Rodriguez P, Nieder AM, Varella M, Barengo NC. Insurance status as a modifier of the association between race and stage of prostate cancer diagnosis in Florida. Poster presentation, American Public Health Association Annual Meeting, San Diego, CA. November 2018. 32. Morales J, Malles A, Kimble M, Rodriguez P, Nieder AM, Barengo NC. Racial disparities in cancer related mortality in patients with urinary bladder malignancy in the US. Poster presentation, Southeastern Section AUA. Phoenix, AZ, March 2019. 33. Wayne G, Wei J, Pereira J, Nieder AM, Bhandari A. Trends in patient positioning for robotic prostatectomy: results from a survey of the endourological society. Poster presentation, Southeastern Section AUA. Phoenix, AZ, March 2019. 34. Nolte A, Wayne G, Cedeno J, Nagoda E, Perez A, Lopategui D, Pereira J, Bhandari A, Nieder AM. Prostate cancer screening: a single institution experience. Poster presentation, Southeast Section AUA, New Orleans, LA, March 2020. 35. Demus T, Vieweg J, Lopatagui D, Nieder AM. Variations in opiod use following radical prostatectomy. Poster presentation, Southeastern Section AUA. Nashville, TN, April 2021. 36. George K, Mallory C, Grant K, Wayne G, Nieder AM. The cost of TURP varies substantially at hospitals in the same geographic location. Poster presentation, Southeastern Section AUA. San Juan, PR, March 2022. 37. Mallory C, Grant K, George K, Wayne G, Nolte A, Nieder AM. Assessing Price Transparency for Price-List Data of Common Urological Procedures. Poster presentation, Southeastern Section AUA. San Juan, PR, March 2022. Alan M. Nieder, M.D. 39 Invited Lectures: “Evaluation and work-up of hematuria.” SUNY Stony Brook, Department of Family Practice, September 2004. “Testis carcinoma: diagnosis and treatment.” SUNY Stony Brook, Department of Endocrinology, Grand Rounds, March 2005. “Management of superficial bladder cancer.” Second Annual Maurice Gonder Urology Symposium: Advances in Adult & Pediatric Urology, SUNY Stony Brook, March 2005. “Introduction to cystoscopy.” ACMI Laser Training Course, University of Miami, July 2005. “Hematuria and bladder cancer.” Mount Sinai Medical Center, Department of Medicine, Grand Rounds, September 2005. “Prostate cancer: diagnosis and treatment.” Mount Sinai Medical Center, Department of Medicine, Resident Rounds, December 2005. “Renal cell carcinoma: diagnosis, evaluation and treatment.” Mount Sinai Medical Center, Department of Medicine, Resident Rounds, January 2006. “Urinary retention and catheter placement.” Mount Sinai Medical Center, Department of Nursing, June 2006. “Lower urinary tract symptoms.” Mount Sinai Medical Center, Department of Medicine, Resident Rounds, December 2006. “Renal cell carcinoma: state of the art.” Mount Sinai Medical Center, Department of Medicine, Grand Rounds, April 2007. “Why bladder cancer matters.” Mount Sinai Medical Center, Doctors Day, March 2008. “Urology for surgeons.” Mount Sinai Medical Center, Surgical Grand Rounds, May 2008. “Foley Catheterization and Continuous Bladder Irrigation.” Mount Sinai Medical Center, Department of Nursing, September 2008. “Bladder Cancer,” Jamaican Urologic Association Annual Meeting, Kingston, Jamaica, February 2009. “Advances in Kidney Cancer,” Mount Sinai Medical Center, Department of Medicine, Grand Rounds, September 2009. Alan M. Nieder, M.D. 40 “Prostate Cancer and Robotic Prostatectomy,” The Grand Bahamas Medical and Dental Association, 9th Annual Scientific Medical Conference, Freeport, Bahamas, October 2009. “Prostate Cancer, State-of-the-Art,” Lower Keys Medical Center, Grand Rounds, Key West, Florida, October 2010. “Surgical management of renal cell carcinoma.” Jamaican Urologic Association Annual Meeting, Kingston, Jamaica, February 2011. “Urology Basics,” Mount Sinai Medical Center, Surgical Grand Rounds, May 2012. “PSA screening and prostate cancer,” Eleventh Annual Primary Care Focus Symposium, Baptist Health, Marco Island, Florida, June 2012. “Bladder cancer: How we can improve outcomes.” Jamaican Urologic Association Annual Meeting, Kingston, Jamaica, February 2013. “Hematuria workup: 2013,” Florida Urologic Society Annual Meeting, Tampa, FL, August 2013. “Contemporary surgical management of renal cell carcinoma.” Jamaican Urologic Association Annual Meeting, Kingston, Jamaica, February 2014. “Negative prostate biopsy.” Florida Urologic Society Annual Meeting, Miami Beach, FL, August 2014. “Robotic surgery update.” Florida International University HWCOM Medical Congress, Miami Beach, FL, July 2015. “Prostate cancer and testosterone: what is the risk?” Florida Urologic Society Annual Meeting, Orlando, FL, September 2015. “Management options for high-grade T1 BCG-refractory bladder cancer.” Moffitt Cancer Center: New Frontiers in Urologic Oncology, Tampa, FL, September 2015. “Future of biomarkers for urothelial malignancies.” Moffitt Cancer Center: New Frontiers in Urologic Oncology, Tampa, FL, September 2015. “Bladder cancer: How we can improve outcomes.” Moffitt Cancer Center: Bladder Cancer Symposium, Fort Myers, FL, November 2016. “Urology Malpractice.” Florida Urologic Society Annual Meeting, Orlando, FL, December 2021. Alan M. Nieder, M.D. 41 Community Lectures: “Diagnosis and Treatment of Prostate Cancer.” Cuban Synagogue, Miami Beach, Fl, October 2003. “Prostate Cancer: Modern Diagnosis and Treatment.” American Urologic Association Foundation, Prostate Health Conference. Florida Atlantic University, Boca Raton, FL, November 2005. “Sexuality & Aging.” Mt. Sinai Foundation. Fisher Island, FL, January 2006. “Should smokers be screened for bladder cancer?” American Urologic Association Foundation, Bladder Cancer Advocacy Network. Florida Atlantic University, Boca Raton, FL, March 2007. “The team approach to prostate cancer.” Gilda’s Club, Ft. Lauderdale, FL. September 2007. “State-of-the-art diagnosis and management of prostate cancer.” Sunny Isles Beach, April 2008. “State-of-the-art diagnosis and management of BPH.” North Miami Beach, May 2008. “Prostate cancer.” Gilda’s Club, Ft. Lauderdale, FL. November 2008. “Prostate Cancer: diagnosis and treatment.” Aventura Community Center, Aventura, FL, September 2009. “Bladder cancer.” Gilda’s club, Ft. Lauderdale, FL January 2010. “Prostate Cancer.” Aventura Turnberry Jewish Center. Aventura, FL. January 2010. “Bladder Cancer: contemporary management.” Mount Sinai Medical Center, Young Founder’s Club. Miami Beach, FL, March 2011. “How to prevent urologic problems.” Young Israel, Century Village, Pembroke Pines, FL, January 2012.